NCT06570031 2025-07-02ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast CancerOno Pharmaceutical Co. LtdPhase 1 Active not recruiting46 enrolled